Elevated neutrophil to lymphocyte ratio to predict survival outcome after recurrence for patients with triple-negative breast cancer.

Authors

Toshiaki Iwase

Toshiaki Iwase

Department of General Surgery, Chiba University Graduate School of Medicine, Chiba, Japan

Toshiaki Iwase , Takafumi Sangai , Masahiro Sakakibara , Takeshi Nagashima , Masaru Miyazaki

Organizations

Department of General Surgery, Chiba University Graduate School of Medicine, Chiba, Japan, Chiba University Graduate School of Medicine, Chiba, Japan, Departments of General Surgery, Chiba University Graduate School of Medicine, Chiba, Japan

Research Funding

No funding sources reported

Background: Recent studies show that obesity plays a major role in causing chronic inflammation by producing several inflammatory cytokines. On the other hand, there is limited research focusing on the effect of obesity in recurrent breast cancer treatments. Therefore, we set out to clarify the impact of obesity related inflammation by Neutrophil to Lymphocyte ratio (N/L ratio) in recurrent breast cancer treatment. Methods: From January 2005 to December 2014, 93 patients with recurrent breast cancer after surgery were included. World Health Organization body mass index (BMI) classification was used for evaluating the degree of obesity. Muscle mass amount was also analyzed. Lumber skeletal muscle index (LSMI, cm2/m2) was generated by standardizing each patient’s muscle area (m2) at the third lumber vertebrae level in axial CT data. Less than 50m2 in LSMI was defined as pre-sarcopenia. N/L ratio was calculated from the laboratory data, and more than 3.0 was defined as high N/L group. Results: Patient background showed there were 20 overweight patients and 2 obese patients. Twenty-eight cases had pre-sarcopenia. In univariate analysis, N/L ratio had no significant differences among BMI categories. However, triple negative (TN) type demonstrated significantly high N/L ratio compared to other subtypes (p < 0.05). LMSI had significant negative correlation to N/L ratio (p < 0.05). In survival analysis, Overweight/Obese group showed significantly shorter OS (p < 0.05). High N/L ratio group also showed similar results (p < 0.05). When stratified by intrinsic subtypes, TN type demonstrated significantly shorter OS (p < 0.05). Additionally, Overweight/Obese groups in TN type had notably shorter OS (p < 0.05). In multivariate analysis, subtype and N/L ratio were independently related to OS (Hazard ratio: 3.3 in TN type, 2.9 in High NL ratio group). Conclusions: Present study did not show any significant relationship between obesity and chronic inflammation in recurrent breast cancer setting. On the contrary, intrinsic subtype was significantly related to inflammation, leading to pre-sarcopenia and worse OS. Whether obesity promotes inflammation in TN type needs more investigation.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Abstract Details

Meeting

2015 Breast Cancer Symposium

Session Type

Poster Session

Session Title

Poster Session A: Risk Assessment, Prevention, Early Detection, Screening, and Local/Regional Therapy

Track

Local/Regional Therapy,Systemic Therapy,Risk Assessment, Prevention, Early Detection, and Screening

Sub Track

High Risk

Citation

J Clin Oncol 33, 2015 (suppl 28S; abstr 24)

DOI

10.1200/jco.2015.33.28_suppl.24

Abstract #

24

Poster Bd #

E6

Abstract Disclosures

Similar Abstracts

Abstract

2023 ASCO Annual Meeting

Obesity and triple negative breast cancer diagnosis among premenopausal women.

First Author: Caitlin Taylor

Abstract

2023 ASCO Annual Meeting

Obesity and breast cancer in women under age 40.

First Author: Rabia Cattie

First Author: Mody Amin